Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENDOTHELIN-2
2024-515928-36-00Phase 2Completed
- Sponsor
- Rouen University Hospital
- Start
- Aug 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of bosentan in arterial hypertension (HTN) (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Change in endothelium-dependent radial artery dilatation. Started Aug 2024; status: completed.
02
Drugs
bosentan
03
Conditions
arterial hypertension (HTN)
Beyond the preview
Go deeper on 2024-515928-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515928-36-00.